Tempus

Washington

Tempus is a biotechnology company focused on making precision medicine a reality by applying AI in healthcare, deriving insights from an expansive library of clinical data and molecular data.

Tempus's valuation today

Estimated valuation today

$53M

-99.38% since last round

Calculated based on estimated multiplier and revenue.

Estimated multiplier for Tempus

2.46x revenue

Calculated based on public comps and hype multiple.

Revenue

Update this based on your knowledge or projections. Calculations use last 12 months revenue.

million

Hype Multiple

Currently selected comps have a median growth rate of 11.40%

This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.

multiple

Shares are worthless

In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.

Last round

The last round was 4 months ago.

Date

April 2022

Valuation

$8.5B

Amount raised

$250M

Public market comparisons

We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.

Multiple at last round

1.62x revenue

Today's multiple

1.64x revenue

Change

1.30%

Companies

Industry – Healthcare

Last updated 5 mins ago.

RemoveNameTicker Price multiple
Tempus

1.64x
1Life Healthcare Inc

ONEM

4.38x
HCA Holdings Inc

HCA

1.04x
Tenet Healthcare Corporation

THC

0.37x
Quest Diagnostics Incorporated

DGX

1.51x
Humana Inc

HUM

0.67x
Valuation history
Fundraising rounds
DateRound Amount raised
Price per share (Preferred)
Valuation
Apr 2022Series G-3$250MM$57.31$8.53B
Dec 2020Series G-2$197.89MM$57.31$8.12B
Mar 2020Series G$97.31MM$38.35$5.02B
May 2019Series F$200MM$24.76$3.17B
Aug 2018Series E$111.02MM$16.74$2.17B
Mar 2018Series D$80MM$9.37$1.03B
Sep 2017Series C$70MM$7.16$759.82MM
Apr 2017Series B-2$30MM$7.16$584.99MM
Nov 2016Series B-1$10MM$4.00$286MM
Jun 2016Series B$10MM$1.86$143.02MM
Sep 2015Series A$10MM$1.00$66.67MM

With a revenue of $22M and a Hype Multiple of 1.5x,
Tempus is estimated to be worth $53M.